{"disease":{"id":"familial-cold-autoinflammatory-syndrome","name":"familial cold autoinflammatory syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00887939","title":"Pathogenesis of Physical Induced Urticarial Syndromes","phase":"","overall_status":"COMPLETED","enrollment_count":173,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT01576367","title":"Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04868968","title":"Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}